Site Members can sign up for company wide alerts
Investigation Overview
An investigation on behalf of investors of K-V Pharmaceutical Company (NYSE:KV.A) over possible violations of Federal Securities Laws in connection with Makena was announced. The investigation by a law firm focuses on certain statements made in connection with Makena. Makena is a drug treatment indicated to reduce the risk of preterm birth in women with a singleton pregnancy who have ...
You must register (for free) or login to view the entire investigation.